The Delaware Thoroughbred Racing Commission has issued fines to two different trainers over failure to follow proper medication procedures, according to recent rulings listed on the Association of Racing Commissioners International website.
Trainer Juan Arriagada was fined $1,500 after a routine barn search on June 21, 2022, revealed the presence of thyroxine in an unlabeled container of methocarbamol. The trainer's violation is twofold: there was an unlabeled/mislabeled medication in his barn, and Arriagada did not follow the proper protocol for thyroxine.
Thyroxine is a prohibited substance in Delaware; trainers may not have thyroxine on their premises on the racetrack unless the horse has been diagnosed with hypothyroidism pursuant to a thyroid releasing hormone stimulation test. That test must be submitted to the state veterinarian, and if the state veterinarian approves, the horse may be treated with only FDA approved medications for hypothyroidism prescribed by the veterinarian.
Trainer Benjamin W. Perkins was fined $1,000 when an out-of-competition test revealed the presence of clenbuterol in the unraced 3-year-old St Jude. The colt has been placed on the vet's list, and will be ineligible to race until he completes a timed workout in front of a commission veterinarian and both blood and urine sampling show no detectable clenbuterol.
Delaware's regulations prohibit clenbuterol use in racing and training unless specific conditions are met:
- The prescription for clenbuterol is made for a specific horse based upon a specific diagnosis. The prescription and volume dispensed cannot exceed a treatment period of 30 days.
- The veterinarian must provide a copy of the prescription and diagnosis to the Commission Veterinarian for review and approval. The horse may not receive clenbuterol before this approval is issued.
- Trainers must make daily notification to the Commission Veterinarian of horses in their custody having been administered clenbuterol. Notification shall be made on a form and by a deadline designated by the Commission.
- A horse administered clenbuterol shall be placed in the Commission Veterinarian's list. The horse must meet all conditions for removal from the list including a timed workout and blood and urine sampling. Both samples must have no detectable clenbuterol.
The post Delaware Commission Fines Arriagada, Perkins Over Failure To Follow Proper Medication Procedures appeared first on Horse Racing News | Paulick Report.
